Case Reports in Nephrology
Volume 2020 (2020), Article ID 7293470, 1 page
https://doi.org/10.1155/2020/7293470

Corrigendum

Corrigendum to “The Association of TNF-Alpha Inhibitors and Development of IgA Nephropathy in Patients with Rheumatoid Arthritis and Diabetes”

Vedran Premužić,¹ Ivan Padjen,² Mislav Cerovec,² Mario Laganović,¹ Tajana Željković-Vrkić,¹ Jelena Kos,¹ Marijana Ćorić,³ Bojan Jelaković,¹ and Branimir Anić²

¹Department of Nephrology, Hypertension, Dialysis and Transplantation, University Hospital Centre Zagreb, Kispaticeva 12, Zagreb 10000, Croatia
²Department of Immunology and Rheumatology, University Hospital Centre Zagreb, Kispaticeva 12, Zagreb 10000, Croatia
³Department of Pathology, University Hospital Centre Zagreb, Kispaticeva 12, Zagreb 10000, Croatia

Correspondence should be addressed to Vedran Premužić; vpremuzic@gmail.com

Received 17 August 2020; Accepted 17 August 2020; Published 4 September 2020

Copyright © 2020 Vedran Premužić et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

In the article titled “The Association of TNF-Alpha Inhibitors and Development of IgA Nephropathy in Patients with Rheumatoid Arthritis and Diabetes” [1], Dr. Mario Laganović, Dr. Tajana Željković-Vrkić, and Dr. Jelena Kos were missing from the authors’ list. The authors contributed towards obtaining, analysing, and interpreting the data presented in the study. The corrected author list is shown above.

References

V. Premužić, I. Padjen, M. Cerovec, M. Ćorić, B. Jelaković, and B. Anić, “The association of TNF-alpha inhibitors and development of IgA nephropathy in patients with rheumatoid arthritis and diabetes,” Case Reports in Nephrology, vol. 2020, Article ID 9480860, 8 pages, 2020.